Mehmet Çınar

Mehmet Çınar

Auto-generated profile, based on publicly available information

Mehmet Çınar

Department of Obstetrics and Gynecology, Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2011 in Endocrine
Verified
Journal Article
Closed access
PDF file
BDBerna Dilbaz
Berna Dilbaz
EOEnis Ozkaya
Enis Ozkaya
MCMehmet Cinar
Mehmet Cinar
ECEvrim Cakir
Evrim Cakir
SDSerdar Dilbaz
Serdar Dilbaz

22 February 2018 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
ŞÖŞule Özel
Şule Özel
SOSebnem Ozyer
Sebnem Ozyer
OAOsman Aykut
Osman Aykut
MÇMehmet Çinar
Mehmet Çinar
OYOmer Hınc Yılmaz
Omer Hınc Yılmaz
YEYaprak Engin-Üstün
Yaprak Engin-Üstün
Purpose: Neural tube defects (NTDs) are the most common malformations of the central nervous system (CNS). There is continuing research for the identification of risk factors and interventions for prevention of NTDs. The aim of this study was to investigate the maternal second trimester blood levels of selected heavy metals namely, arsenic (As), cadmium (Cd), mercury (Hg), manganese (Mn), nickel (Ni), and lead (Pb) and their possible relation with the occurrence of NTDs. Methods: Twenty-one healthy second trimester pregnant women with fetuses affected with NTD (cases) were matched with 21 healthy pregnant women with unaffected fetuses (controls) with respect to age, body mass index (BMI), and gestational age. Maternal blood levels of heavy metals were measured after an overnight fasting period. Results: No significant differences were observed in terms of maternal blood levels of As, Cd, Hg, and Ni between NTD-affected and unaffected pregnancies. The blood Pb and Mn levels were found to be higher in pregnant women with a fetus affected with NTD when compared with pregnant women with unaffected fetuses (for Pb, in cases 12.3 ± 5.5 µg/L, in controls 7.8 ± 2.4 µg/L; for Mn in cases 3.6 ± 1.4 µg/L, in controls 2.4 ± 1.0 µg/L, p < .05). Conclusions: High maternal second trimester blood levels of Pb and Mn during pregnancy are associated with NTDs in the newborn.

1 September 2015
Verified
Journal Article
Closed access
ATAytekin Tokmak
Aytekin Tokmak
GYGülçin Yıldırım
Gülçin Yıldırım
ESEsma Sarıkaya
Esma Sarıkaya
MÇMehmet Çınar
Mehmet Çınar
NBNihal Boğdaycıoğlu
Nihal Boğdaycıoğlu
NYNafiye Yılmaz
Nafiye Yılmaz
PURPOSE: The aim of this study was to evaluate serum levels of inducible nitric oxide synthase (INOS), myeloperoxidase (MPO), total antioxidant status (TAS), and total oxidative status (TOS) in women with primary ovarian insufficiency (POI) and to compare them with healthy fertile women. We also examined the possible risk factors associated with POI. METHODS: This cross-sectional case control study was conducted in Zekai Tahir Burak Women's Health Education and Research Hospital. The study population consisted of 44 women with POI (study group) and 36 healthy fertile women (control group). In all patients, serum levels of INOS, MPO, TAS, and TOS were determined. INOS and MPO levels were measured by enzyme-linked immunosorbent assay whereas colorimetric method was used for evaluating TAS and TOS levels. Age, body mass index (BMI), obstetric history, smoking status, family history, comorbidities, sonographic findings, complete blood count values, C-reactive protein and baseline hormone levels were also analyzed. Student's t-test or Mann-Whitney U test was used to compare continuous variables between the groups; categorical data were evaluated by using Pearson chi(2) or Fisher exact test, when appropriate. Binary logistic regression method was used to identify risk factors for POI. RESULTS: We found significantly elevated levels of INOS (234.1 +/- 749.5 versus 133.8 +/- 143.0; p=0.005), MPO (3,438.7 +/- 1,228.6 versus 2,481.9 +/- 1,230.1; p=0.001), and TOS (4.3 +/- 1.4 versus 3.6 +/- 1.4; p=0.02) in the sera of the study group when compared to the BMI-age matched control group. However, difference in serum levels of TAS were not significant between the 2 groups (1.7 +/- 0.2 versus 1.6 +/- 0.2; p= 0.15). Logistic regression method demonstrated that BMI <25 kg/m(2), nulliparity, family history of POI, smoking, and elevated serum levels of INOS, MPO, and TOS were independent risk factors for POI. CONCLUSION: We found an increase in INOS, MPO, and TOS in women with POI. These serum markers may be promising in early diagnosis of POI. Further large-scale studies are required to determine whether oxidative stress markers have a role in diagnosing POI.

22 March 2018 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
HKHatice Kansu-Celik
Hatice Kansu-Celik
YTYasemin Tasci
Yasemin Tasci
BKBurcu Kisa Karakaya
Burcu Kisa Karakaya
MCMehmet Cinar
Mehmet Cinar
TCTuba Candar
Tuba Candar
GCGamze Sinem Caglar
Gamze Sinem Caglar
Objective: To evaluate the value of maternal serum advanced glycation end products (AGEs) level at 11–13 weeks’ gestation for the prediction of preterm labor and or preterm premature rupture of membranes (PPROM). Materials and methods: This prospective cross-sectional study is performed in a university-affiliated hospital between February and April 2016. The participants of this study are low-risk pregnant women. Blood samples for maternal AGEs level were collected in the first trimester of pregnancy and all women completed their antenatal follow-up and delivered in our center. During the follow-up 21 women developed preterm labor/PPROM. The first trimester maternal AGEs levels of preterm labor/PPROM cases were compared with uncomplicated cases (n = 25) matched for age-parity and BMI. The predictive value of AGEs levels for preterm labor/PPROM was also assessed. Results: First-trimester AGEs levels were significantly higher in cases complicated with preterm labor/PPROM (1832 (415–6682) versus 1276 (466–6445) ng/L, p = .001 and 1722 (804–6682) versus 1343 (466–6445) ng/L, p = .025). According to receiver-operating characteristic curve analysis, the calculated cut off value of AGEs was 1538 ng/L with the sensitivity 91.7%, specificity 73.8%; and the negative and positive predictive values were 91.6% and 29.5%, respectively. Conclusions: For the prediction of preterm labor/PPROM, the relatively high AGEs levels in the first trimester might be a useful marker.

1 December 2012 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Closed access
BDBerna Dilbaz
Berna Dilbaz
MCMehmet Cinar
Mehmet Cinar
EOEnis Ozkaya
Enis Ozkaya
NTNazan Vanli Tonyali
Nazan Vanli Tonyali
SDSerdar Dilbaz
Serdar Dilbaz
The aim of this study was to evaluate the clinical features and health quality profile differences between infertile women with polycystic ovary syndrome (PCOS) phenotypes and women with unexplained infertility. The WHOQOL-BREF were administered in a cross-sectional survey to 132 women diagnosed with PCOS (study group) and 32 women diagnosed with unexplained infertility (control group). Body mass index (BMI), duration of infertility (DOI), type of infertility (TOI) and Ferriman Gallwey scores (FG scores), were compared between the study and control groups and between different phenotype groups of PCOS: Group 1-Hyperandrogenemia (HA)-anovulation (N=34), Group 2-HA-PCO (ovulatory PCOS, (N=34), Group 3-PCO-anovulation (N=32), and Group 4-HA-PCO-anovulation (N=32) and the associations of these parameters with the health quality profile were analyzed. Physical, Spiritual and Environmental scores were significantly lower (p<0.05) in Group 1 patients (HA-AO) in comparison to the other three PCOS groups and the control group, while the same difference was observed in the social scores with a near significance (p=0.05). Linear regeression analyses revealed significant associations between type of infertility (beta coefficient: -0.423, p=0.001), FG score (beta coefficient: -0.177, p=0.016), phenotype 1 (beta coefficient: -0.236, p=0.002) and physical scores. Psychological scores were associated with the type (beta coefficient: -0.641, p=0.001) and duration (beta coefficient: -0.149, p=0.009) of infertility. Scores in the social area were only associated with type of infertility (beta coefficient: -0.443, p=0.001). Scores of environmental area were significantly associated again with the type of infertility (beta coefficient: -0.499, p=0.001) and FG scores (beta coefficient: -0.195, p=0.008). Primary infertility was a risk factor for low physical (odds ratio: 8.100, 95% CI: 3.827-17.142), social (odds ratio: 9.183, 95% CI: 4.084-20.648) and environmental (odds ratio: 9.966, 95% CI: 4.623-21.468) scores determined according to the median level. FG scores, primary infertility and phenotype 1 PCOS were associated with lower health quality of life scores. Infertile women with Phenotype 1 (HA-AO) had the lowest scores.

1 August 2016 in Journal of the Chinese Medical Association
Verified
Journal Article
Open access
MÇMehmet Çinar
Mehmet Çinar
ATAytekin Tokmak
Aytekin Tokmak
AGAli Irfan Güzel
Ali Irfan Güzel
RARifat Taner Aksoy
Rifat Taner Aksoy
IÖİrFan Özer
İrFan Özer
MDMelike Doğanay
Melike Doğanay
This study aimed to evaluate the association between complications and clinical parameters with obesity in 273 women who have undergone abdominal myomectomy during the study period. The patients were classified into two groups according to body mass index (BMI) (≤30 kg/m(2) and >30 kg/m(2)). Demographic, preoperative and postoperative clinical parameters were evaluated. Demographic, preoperative and postoperative clinical parameters were evaluated. The results showed statistically significant differences between the obese and non-obese groups in terms of age, gravidity, diameter of fibroid (DOF), postoperative hemoglobin, duration of hospital stay, and complications. Patients in the obese group had greater DOF and complications such as hemorrhage, postoperative fever, wound infection and ileus (p < 0.05). Based on our results, we conclude that obesity adversely affects the clinical outcomes of patients who undergo abdominal myomectomy.